A phase I, open-label, two-period study to evaluate the pharmacokinetic effects of concomitant ketoconazole on mifepristone

Trial Profile

A phase I, open-label, two-period study to evaluate the pharmacokinetic effects of concomitant ketoconazole on mifepristone

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Oct 2017

At a glance

  • Drugs Mifepristone (Primary) ; Ketoconazole
  • Indications Breast cancer; Cushing syndrome; Induced abortion; Prostate cancer
  • Focus Pharmacokinetics
  • Most Recent Events

    • 20 Oct 2017 New trial record
    • 11 Oct 2017 Results published in the Advances in Therapy
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top